Glancy Prongay & Murray Reminds Investors of the July 6, 2015 Deadline in the Class Action Lawsuit Against Insulet Corp.
July 01 2015 - 09:07PM
Business Wire
Glancy Prongay & Murray reminds investors that a class
action has been filed on behalf of investors in Insulet Corp.
(“Insulet” or the “Company”) (NASDAQ: PODD), who purchased Insulet
securities between February 27, 2013 and April 30, 2015, inclusive
(the “Class Period”). Insulet investors have until July 6, 2015 to
file a lead plaintiff motion.
Insulet is primarily engaged in the development, manufacturing
and sale of its proprietary OmniPod Insulin Management System (the
“OmniPod System”), an insulin infusion system for people with
insulin-dependent diabetes.
The complaint filed against the Company alleges that Defendants
made false and/or misleading statements, as well as failed to
disclose material adverse facts about the Company’s business,
operations, and prospects. Specifically, Defendants failed to
disclose: (1) that the Company was experiencing slower demand for
its products; (2) that the Company was facing issues with its sales
and marketing efforts; (3) that, as a result, the Company
experienced unevenness in its financial performance; and (4) that,
as a result of the foregoing, Defendants’ positive statements about
the Company’s business, operations, and prospects lacked a
reasonable basis. As a result of Defendants’ wrongful acts and
omissions, and the precipitous decline in the market value of the
Company’s securities after disclosing the decline in its revenues,
investors have suffered significant losses and damages.
If you purchased Insulet shares or have information or would
like to learn more about these claims, or have any questions
concerning this announcement, please contact Lesley Portnoy, of
Glancy Prongay & Murray, 1925 Century Park East, Suite 2100,
Los Angeles, California 90067 at 310-201-9150, Toll-Free at
888-773-9224, by email to shareholders@glancylaw.com, or visit our
website at http://www.glancylaw.com. If you inquire by email please
include your mailing address, telephone number and number of shares
purchased.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150701006740/en/
Glancy Prongay & Murray, Los AngelesLesley
Portnoy310-201-9150 or
888-773-9224shareholders@glancylaw.comwww.glancylaw.com
Insulet (NASDAQ:PODD)
Historical Stock Chart
From Feb 2024 to Mar 2024
Insulet (NASDAQ:PODD)
Historical Stock Chart
From Mar 2023 to Mar 2024